에스씨엠생명과학

298060KOSDAQ의약품 제조업

39.3 / 100

Reference Date: 2026-04-13

Financial Score16.0 / 40

News Sentiment8.3 / 25

Momentum5.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Slightly down 1.4% over the past month, and news sentiment is negative.

Company InformationBased on 2025 Annual Report

Business Overview

SCM Life Science is a biotech company that develops high-purity stem cell therapeutics using its proprietary layer separation culture technology. It is conducting clinical trials for treatments targeting chronic graft-versus-host disease, acute pancreatitis, and atopic dermatitis. Additionally, it has launched the dermocosmetic brand 'Iroro,' leveraging CXCL1 protein and hPL cultivation technology, and is expanding globally through international sales agreements.

Number of Employees

25people

Average Salary

37.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

138.67Industry Average 14.800.0Point

9.4x industry avg (risky)

PBR

1.02Industry Average 1.044.0Point

In line with industry avg

ROE

0.81Industry Average 4.421.0Point

Well below industry avg

Debt Ratio

7.36Industry Average 11.985.0Point

Lower than industry avg (good)

Trend 2023~20256.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲1404.4% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲36.5% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -59.1% (improving, 3yr)

Detailed News Sentiment

9 totalPositive 0Neutral 0Negative 5Average Sentiment Score 20

Negative
한국거래소 “에스씨엠생명과학 시장조치 오류 투자자 배상 착수”
한국거래소가 에스씨엠생명과학 시장조치 오류로 피해를 본 투자자들을 대상으로 손해배상 방안 마련에 착수했다.
Negative
거래소, ‘관리종목 해제 실수’에 “손해배상 심의위 설치 예정”
한국거래소가 코스닥 상장사의 관리종목 해제 실수에 따른 투자자 손해배상을 위해 외부 전문가로 구성된 심의위원회를 꾸린다고 밝혔다.
Negative
한국거래소 "에스씨엠생명과학 사고, 배상심의위 설치예정"
한국거래소가 에스씨엠생명과학 관리종목 해제사고에 대해 다음달 초 외부전문가로 구성한 '배상심의위원회'를 구성하겠다고 밝혔다.

Detailed Momentum

52-week position1.0Point

Near 52w low (10%, downtrend)

Current 832Won52-week high 1,40552-week low 764

1-month return3.0Point

1m -1.42% (flat)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

12 totalPositive 0Neutral 12Negative 0

Neutral전환가액의조정 (제2회차)2026-04-02
Neutral주주총회소집결의2026-04-01
Neutral주주명부폐쇄기간또는기준일설정2026-04-01
Neutral합병등종료보고서(합병)2026-04-01
Neutral[기재정정]정기주주총회결과2026-03-31